Don’t miss this engaging article that explores the current and emerging treatment landscape in immune thrombocytopenic purpura (ITP). New therapeutic approaches to ITP are urgently needed to address unmet clinical needs.
In this issue
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given